Foundation Medicine Revenue and Competitors
Estimated Revenue & Valuation
- Foundation Medicine's estimated annual revenue is currently $555.5M per year.
- Foundation Medicine received $56.0M in venture funding in January 2013.
- Foundation Medicine's estimated revenue per employee is $248,000
- Foundation Medicine's total funding is $96.5M.
- Foundation Medicine's current valuation is $5.3B. (Jul 2018)
Employee Data
- Foundation Medicine has 2240 Employees.
- Foundation Medicine grew their employee count by -4% last year.
Foundation Medicine's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Product Owner | Reveal Email/Phone |
3 | Sr. Product Owner | Reveal Email/Phone |
4 | Chief People Officer | Reveal Email/Phone |
5 | Chief Staff, Research & Development | Reveal Email/Phone |
6 | Chief Staff, Global Portfolio Strategy | Reveal Email/Phone |
7 | Chief Staff, Global Operations | Reveal Email/Phone |
8 | Chief Staff, Corporate Management | Reveal Email/Phone |
9 | Chief Staff, Commercial | Reveal Email/Phone |
10 | Chief Staff, Global Operations | Reveal Email/Phone |
Foundation Medicine Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $343.9M | 3176 | 7% | $550M | $7.9B |
#2 | $34.4M | 149 | -2% | $1.1B | $8.1B |
#3 | $423.6M | 1708 | 5% | $2B | $2.5B |
What Is Foundation Medicine?
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient's cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine's molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer. For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter. Legal and Privacy: http://foundationmedicine.com/legal/
keywords:Biotechnology,Enterprise Software,Healthcare,Medical Diagnostics,Pharmaceuticals
$96.5M
Total Funding
2240
Number of Employees
$555.5M
Revenue (est)
-4%
Employee Growth %
$5.3B
Valuation
N/A
Accelerator
Foundation Medicine News
During Dr. Bachman's tenure at Foundation Medicine, she built and led the team responsible for managing the company's partnership portfolio.
The FPAC role is open to physicians who have an interest in coaching medical students during their pre-clinical years (termed Foundation...
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep...
Foundation Medicine and Epic are partnering to enable clinicians to access genomic profiling and other testing services directly through their EHR system. Announced Thursday, the partnership aims to improve clinical workflow efficiency and offer providers, including oncology practices, access t ...
Chugai Launches FoundationOne Liquid CDx Cancer Genomic Profile as the First Blood-based Comprehensive Genomic Profiling Test for Solid Tumors in Japan FoundationOne Liquid CDx Cancer Genomic Profile is now available for use as a comprehensive genomic profiling test covering 324 genes as well a ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $477.5M | 2436 | 34% | N/A |
#2 | $481.1M | 2658 | N/A | N/A |
#3 | $692.7M | 2749 | 9% | N/A |
#4 | $1202.6M | 2789 | N/A | N/A |
#5 | $749.3M | 2797 | 7% | $3B |
Foundation Medicine Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2010-04-16 | $25.0M | A | Third Rock Ventures | Article |
| 2011-10-19 | $33.5M | Undisclosed | Kleiner Perkins Caufield & Bye, Google Ventures | Article |
| 2012-09-21 | $42.5M | B | Multiple | Article |
| 2013-01-09 | $56.0M | B | Article |